Skip to main content
Clinical Trials/NCT05971771
NCT05971771Not yet recruitingNot Applicable

A Randomized, Double-Blind, Placebo Controlled, Single Center Pilot Study to Assess the Impact of Sleep Supplement on Sleep Health

Pharmanex0 sites40 target enrollmentStarted: August 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Pharmanex
Enrollment
40
Primary Endpoint
Change from baseline sleep quality index

Study Overview

Brief Summary

Sleep is essential for health and wellness. Sleep disruption can occur due to emotional stress, advancing age, hormonal imbalance, medications, and many other causes, some of which are presently unknown. Most pharmaceutical sleep products artificially induce sedation without providing quality sleep. Thus, a need exists for safe dietary supplement to promote and support healthy sleep that will encourage restful sleep. This study will examine the efficacy, tolerance, and safety of sleep supplement as compared to a placebo.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Masking Description

Products will be delivered in forms that it will not be discernable (to participant, investigator, or care provider) as to which product is active or placebo

Eligibility Criteria

Ages
20 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • The subject is male or female 20-60 years of age at the time of informed consent.
  • Recorded baseline BMI is ≥18.5 and ≤29.9 kg/m
  • A score of 5 or higher on the Pittsburgh Sleep Quality Index.
  • Willing and able to give informed consent
  • Willing to maintain consistent diet and physical activity through the study period.
  • Willing to limit alcohol consumption to ≤14 drinks per week, no more than 4 drinks at a time, and no more than 1 drink within 4h of bedtime.
  • Willing to limit caffeine consumption to no more than 4 servings per day and no caffeine within 6h of bedtime.

Exclusion Criteria

  • Could not or did not want to participate in clinical study.
  • Taken nutritional supplements for sleep or stress in the previous 6 months.
  • Have received non-pharmacological treatment for sleep disorders (eg. Cognitive behavioral therapy, relation therapy) in previous 6 months
  • Any known allergy or intolerance to any of the ingredients contained in supplement.
  • Planned surgical procedure during the course of the study.
  • Used nicotine in the past 6 months.
  • Have a major psychiatric disorder as determined by the Mini International Neuropsychiatric Inventory
  • A history of unconventional sleep pattern, a diagnosed sleep disorder, or chronic medical condition that could affect energy/fatigue levels.
  • Consume more than 400mg of caffeine per day in the past 2 weeks.
  • Used any psychotropic medications, stimulants, cannabis, non-registered drug products, or illicit substances in the past 4 weeks.
  • At risk of drug or alcohol abuse
  • Used any sleep aids in the past 2 weeks.
  • Employed in night shift work or rotational shift work
  • Currently pregnant, nursing, planning to become pregnant, or unwilling to use a medically approved form of contraception will be excluded.
  • Individuals who sleep more than 10 hours.
  • Typically take a nap during the day.
  • Those planning travel or vacation during the study period.

Outcomes

Primary Outcomes

Change from baseline sleep quality index

Time Frame: Baseline, Day 1, Day 7, Day 28

Change from baseline in validated Pittsburgh Sleep Quality Index (0-21, higher number indicates poorer quality)

Change from baseline sleep duration and quality from diary

Time Frame: Baseline and Daily for 28 days

Change from baseline with Daily Sleep Diary

Secondary Outcomes

  • Change from baseline perceived stress scale(Baseline, Day 1, Day 7, Day 28)
  • Change from baseline in mood(Baseline, Day 1, Day 7, Day 28)
  • Change from baseline Insomnia severity index(Baseline, Day 1, Day 7, Day 28)
  • Change from baseline in skin attributes(Baseline, Day 7, and Day 28)
  • Change from baseline in restorative sleep as measured by Restorative Sleep Questionnaire (RSQ)(Baseline, Day 1, Day 7, Day 28)

Investigators

Sponsor
Pharmanex
Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials

Study to Assess Impact of Dietary... | Clinical Trial